Compounds > aztreonam

aztreonam and nafcillin

aztreonam has been researched along with nafcillin in 11 studies

Research

Studies (11)

Timeframe	Studies, this research(%)	All Research%
pre-1990	3 (27.27)	18.7374
1990's	1 (9.09)	18.2507
2000's	3 (27.27)	29.6817
2010's	4 (36.36)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL	1
Lombardo, F; Obach, RS; Waters, NJ	1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV	1
Hayashi-Nishino, M; Nishino, K; Yamaguchi, A; Yamasaki, S	1
Anderson, KC; Kellogg, GE; Sarkar, A	1
Bommareddy, A; Gionfriddo, MR; Heindel, GA; Mukhija, P; Vanwert, AL; Witkowski, S; Wolman, AT	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Lipford, LC; Riley, CM	1
Fass, RJ; Helsel, VL	1
Adamovics, J; Creasey, WA; Dhruv, R; Platt, TB; Sugerman, AA	1
Hamill, RJ; Ilahi, OA; Swarna, U; Tullos, HS; Young, EJ	1

Reviews

2 review(s) available for aztreonam and nafcillin

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
Concomitant crystal and septic arthritis. Orthopedics, 1996, Volume: 19, Issue:7 Topics: Adult; Aged; Aged, 80 and over; Arthritis, Gouty; Arthritis, Infectious; Aztreonam; Escherichia coli Infections; Female; Humans; Male; Middle Aged; Monobactams; Nafcillin; Penicillins; Staphylococcal Infections	1996

Other Studies

9 other study(ies) available for aztreonam and nafcillin

Article	Year
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. Current drug discovery technologies, 2004, Volume: 1, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration	2004
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Physicochemical determinants of human renal clearance. Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15 Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight	2009
Effect of NlpE overproduction on multidrug resistance in Escherichia coli. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:5 Topics: Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Copper; Drug Resistance, Bacterial; Drug Resistance, Multiple; Escherichia coli; Escherichia coli Proteins; Gene Expression Regulation, Bacterial; Lipoproteins; Membrane Transport Proteins; Microbial Sensitivity Tests; Reverse Transcriptase Polymerase Chain Reaction	2010
Computational analysis of structure-based interactions and ligand properties can predict efflux effects on antibiotics. European journal of medicinal chemistry, 2012, Volume: 52 Topics: Anti-Bacterial Agents; beta-Lactams; Computational Biology; Drug Resistance, Bacterial; Hydrophobic and Hydrophilic Interactions; Ligands; Membrane Transport Proteins; Microbial Sensitivity Tests; Models, Molecular; Protein Binding; Protein Conformation; Quantitative Structure-Activity Relationship; Regression Analysis; Thermodynamics	2012
Organic anion transporter 3 interacts selectively with lipophilic β-lactam antibiotics. Drug metabolism and disposition: the biological fate of chemicals, 2013, Volume: 41, Issue:4 Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Biological Transport; Cell Line, Transformed; Humans; Mice; Organic Anion Transport Protein 1; Organic Anion Transporters, Sodium-Independent; Solubility; Structure-Activity Relationship	2013
Interaction of aztreonam with nafcillin in intravenous admixtures. American journal of hospital pharmacy, 1986, Volume: 43, Issue:9 Topics: Aztreonam; Drug Interactions; Drug Stability; Injections, Intravenous; Nafcillin; Solutions	1986
In vitro activity of carumonam. Antimicrobial agents and chemotherapy, 1985, Volume: 28, Issue:6 Topics: Anti-Bacterial Agents; Aztreonam; Clindamycin; Drug Synergism; Enterobacteriaceae; Gram-Negative Aerobic Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Nafcillin; Piperacillin; Tobramycin	1985
Pharmacokinetic interaction of aztreonam with other antibiotics. Journal of clinical pharmacology, 1984, Volume: 24, Issue:4 Topics: Adult; Anti-Bacterial Agents; Aztreonam; Cephradine; Clindamycin; Drug Interactions; Gentamicins; Humans; Kinetics; Male; Metronidazole; Nafcillin	1984